title: Primary spindle cell sarcoma of the prostate and (18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings.
abstract: BACKGROUND
  Primary sarcoma of the prostate is extremely rare and accounts for 0.1% of all prostate cancers. This type of cancer is associated with poor prognosis due to aggressive biological behavior. The World Health Organization histologically classified prostate sarcomas as stromal tumor of unknown malignant potential (STUMP) and stromal sarcoma.
  
  
  METHODS
  A 39-year-old patient presented with lower urinary tract symptoms over the last few months. On digital rectal examination, the right lobe of the prostate was diffusely hard on palpation. Prostate-specific antigen was 0.5 ng/ml. A biopsy specimen was obtained with the guidance of transrectal ultrasonography. Immunohistochemical examination revealed positive staining for vimentin, actin, and desmin.
  
  
  RESULTS
  (18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography scans obtained for staging purposes with the diagnosis of primary spindle cell carcinoma of the prostate revealed widespread lung and liver metastases. A doxorubicin-based systemic chemotherapy (CTx) was initiated.
  
  
  CONCLUSIONS
  Spindle sarcomas of the prostate have quite aggressive nature and they have high potential to metastase. Average life expectancy is <1 year and the prognosis is poor. CTx and radiation therapy can't yield curative effects due to poor differentiation.
authors: Department of Urology, School of Medicine, Sifa University, Izmir, Turkey.
authors: Hakan
authors: H
authors: Öztürk
keywords: Diagnosis; positron-emission tomography/computed tomography; prostat cancer; sarcoma; spindle cell prostatic sarcoma; treatment
references: Am J Surg Pathol. 2006 Jun;30(6):694-704
references: 16723846
references: Hum Pathol. 2014 Jan;45(1):65-70
references: 24196187
references: Am J Surg Pathol. 2006 Oct;30(10):1316-21
references: 17001164
references: J Clin Oncol. 1996 Mar;14(3):869-77
references: 8622035
references: Cancer. 1995 Oct 15;76(8):1422-7
references: 8620418
references: Eur J Gynaecol Oncol. 2011;32(5):513-5
references: 22053664
references: Korean J Urol. 2011 Oct;52(10):669-73
references: 22087360
references: Int J Clin Exp Pathol. 2010 Feb 05;3(3):319-22
references: 20224731
references: Chin J Cancer. 2013 Dec;32(12):648-52
references: 23731771
references: Hematol Oncol Clin North Am. 1995 Aug;9(4):869-87
references: 7490246
references: Pathologica. 2008 Dec;100(6):482-4
references: 19475893
references: Hinyokika Kiyo. 2008 May;54(5):377-81
references: 18546866
references: Cancer. 1996 Feb 15;77(4):675-82
references: 8616759
references: Case Rep Pathol. 2011;2011:252805
references: 22937380
references: Histopathology. 2012 Jan;60(1):59-74
references: 22212078
references: Am J Surg Pathol. 1998 Feb;22(2):148-62
references: 9500215
references: J Urol. 2005 Feb;173(2):439-40
references: 15643196